Vera Therapeutics
VERA
37 hedge funds and large institutions have $375M invested in Vera Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 0 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 5
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
49% more capital invested
Capital invested by funds: $252M → $375M (+$122M)
19% more funds holding
Funds holding: 31 → 37 (+6)
3.13% less ownership
Funds ownership: 70.15% → 67.02% (-3.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.17M |
| 2 |
BlackRock
New York
|
+$3.12M |
| 3 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$2.67M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$1.11M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Alphabet Inc
Mountain View,
California
|
-$5.11M |
| 2 |
OCA
Octagon Capital Advisors
New York
|
-$557K |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$90.3K |
| 4 |
JP Morgan Chase
New York
|
-$55.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.48K |
VERA Hedge Fund Activity: Q4 2021 in Review
37 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Vera Therapeutics (VERA) for Q4 2021, worth a combined $375M — up 49% from $252M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VERA positions and 0 closed out — a net gain of 7 holders — while 20 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.17M. The largest seller was Alphabet Inc, cutting an estimated $5.11M.
- 37 institutional investors held Vera Therapeutics (VERA) as of Q4 2021, up from 31 in Q3 2021.
- Funds reported $375M of Vera Therapeutics stock for Q4 2021, up 49% quarter-over-quarter.
- 7 funds opened new Vera Therapeutics positions in Q4 2021 and 0 closed out, a net change of +7 holders.
- The largest Vera Therapeutics buyer in Q4 2021 was Vanguard Group, an estimated $3.17M added.
- The largest Vera Therapeutics seller in Q4 2021 was Alphabet Inc, an estimated $5.11M sold.
Based on aggregated 13F filings for Q4 2021.